The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)

AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …

Adenosine and brain function

BB Fredholm, JF Chen, RA Cunha… - Int Rev …, 2005 - books.google.com
A. Cellular and Subcellular Localization B. Pharmacological Tools to Study Adenosine
Receptors C. Signaling Via Adenosine Receptors D. Regulation of Receptor Expression and …

Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia

S Ferré, K Fuxe, BB Fredholm, M Morelli… - Trends in neurosciences, 1997 - cell.com
Increasing evidence suggests that antagonistic interactions between specific subtypes of
adenosine and dopamine receptors in the basal ganglia are involved in the motor …

Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors

RA Cunha - Neurochemistry international, 2001 - Elsevier
Adenosine exerts two parallel modulatory roles in the CNS, acting as a homeostatic
modulator and also as a neuromodulator at the synaptic level. We will present evidence to …

Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade

RA Cunha - Purinergic signalling, 2005 - Springer
Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …

Distribution, biochemistry and function of striatal adenosine A2A receptors

P Svenningsson, C Le Moine, G Fisone… - Progress in …, 1999 - Elsevier
It is well known that the nucleoside adenosine exerts a modulatory influence in the central
nervous system by activating G protein coupled receptors. Adenosine A2A receptors, the …

Targeting adenosine A2A receptors in Parkinson's disease

MA Schwarzschild, L Agnati, K Fuxe, JF Chen… - Trends in …, 2006 - cell.com
The adenosine A 2A receptor has emerged as an attractive non-dopaminergic target in the
pursuit of improved therapy for Parkinson's disease (PD), based in part on its unique CNS …

Adenosine A2A receptors and basal ganglia physiology

SN Schiffmann, G Fisone, R Moresco, RA Cunha… - Progress in …, 2007 - Elsevier
Adenosine A2A receptors are highly enriched in the basal ganglia system. They are
predominantly expressed in enkephalin-expressing GABAergic striatopallidal neurons and …

Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system

DL Rosin, A Robeva, RL Woodard… - Journal of …, 1998 - Wiley Online Library
The A2A adenosine receptor (A2A‐AR) transcript and radioligand binding sites have a
distinct distribution in rat brain, restricted primarily to the striatum, nucleus accumbens and …

Caffeine—an atypical drug of dependence

JW Daly, BB Fredholm - Drug and alcohol dependence, 1998 - Elsevier
Caffeine is the most widely consumed, behaviorally active substance in the world. Average
caffeine consumption in humans can range in different cultures and nations from 80 to 400 …